JOURNAL OF HISTOTECHNOLOGY, published by Taylor & Francis Ltd, is a leading academic journal dedicated to advancing the field of histotechnology, which plays a crucial role in both clinical and research settings. With an established history since 1977, this journal serves as a critical platform for researchers, professionals, and students engaged in the intricate study of tissue processing, staining techniques, and microscopic analysis. It is currently indexed in reputable databases, reflecting its commitment to scientific rigor, with a notable presence in categories such as Anatomy, Histology, and Medical Laboratory Technology. Despite its open access status being limited, the Journal of Histotechnology maintains a respectable impact factor and ranks within the third quartile for Anatomy and Medical Laboratory Technology, and fourth quartile for Histology in 2023, emphasizing its relevance in the scholarly community. As the field continues to evolve, this journal aims to foster innovation and dissemination of knowledge within histotechnology, making it an essential resource for those looking to further their expertise and contribute to the advancements in this vital area of health sciences.

Journal of Statistical Software, published by the esteemed Journal Statistical Software, stands as a premier platform for the dissemination of cutting-edge research in the fields of statistical software development, methodologies, and applications. With an impressive impact factor and consistently ranking in the Q1 quartile for Software, Statistics and Probability, and Statistics, Probability and Uncertainty as of 2023, this journal is recognized globally for its scholarly contributions and innovative content. The journal has been an Open Access publication since 1996, facilitating unrestricted access to high-quality research for a diverse audience, including researchers, professionals, and students. As the journal converges into its 28th volume in 2024, it continues to maintain a strong presence in key academic rankings—evidenced by its stellar Scopus rank, where it is placed in the top 5% of journals in its field. Located at UCLA Department of Statistics, in Los Angeles, this journal is dedicated to fostering the advancement of statistical software and its role in enhancing scientific research across multiple disciplines.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

MethodsX is a premier peer-reviewed journal published by Elsevier, dedicated to advancing the field of applied methods across various disciplines, particularly in Clinical Biochemistry and Medical Laboratory Technology. Since its inception in 2014, this Open Access journal has fostered innovation by allowing researchers to share and access high-quality methodologies designed to enhance reproducibility and effectiveness in research practices. Based in the Netherlands, MethodsX has achieved an impressive ranking in the Scopus database, placing in the top 78th percentile among multidisciplinary journals. The journal is committed to providing researchers, professionals, and students with a platform to disseminate new techniques and strategies, ensuring that groundbreaking methods are readily available to the global scientific community. With a focus on fostering collaboration and interdisciplinary research, MethodsX aims to bridge gaps across various scientific domains and empower future advancements until its converged years in 2024.

METHODS is a premier journal published by Academic Press Inc Elsevier Science, dedicated to advancing the field of Biochemistry, Genetics, and Molecular Biology. With an ISSN of 1046-2023 and E-ISSN 1095-9130, this distinguished journal has established itself as a vital resource since its inception in 1990, providing high-quality research articles and methodological insights crucial for both seasoned researchers and students alike. The journal ranks in the Q1 category for miscellaneous areas within Biochemistry and Genetics, and maintains a Q2 ranking in Molecular Biology, reflecting its impact within the scientific community, evidenced by Scopus rankings that place it in the top 20% of its field. METHODS offers a platform for showcasing innovative research methods and their applications, contributing significantly to the development of new technologies and analytical techniques. Though not an open-access journal, it remains a highly regarded publication that assures readers of rigorous peer review and academic integrity, making it an essential addition to any serious researcher's library.

Cell Reports Methods is a cutting-edge journal published by CELL PRESS, focusing on innovative methodologies in the vast fields of biochemistry, genetics, biotechnology, and radiological sciences. Launched in 2021, it has rapidly ascended to attain a Q1 ranking across multiple disciplines in the latest 2023 metrics, reflecting its influential contribution to the scientific community. With an emphasis on practical and rigorous experimental approaches, this journal serves as a vital resource for researchers looking to advance their methodologies and collaborate on significant findings in their respective specialties. Despite not being an open-access publication, Cell Reports Methods ensures broad accessibility through institutional subscriptions, allowing researchers from various backgrounds to engage with high-quality scholarly work. The journal presents a unique platform for sharing insights from interdisciplinary methods that foster innovation and discovery, ultimately shaping the future of scientific research.

BMC Research Notes, published by SPRINGERNATURE, is a leading open-access journal dedicated to the dissemination of research notes across various disciplines, particularly within the fields of biochemistry, genetics, molecular biology, and medicine. Since its establishment in 2008, the journal has embraced a mission to facilitate the rapid publication of short, concise articles that contribute significantly to ongoing scientific dialogues. With an impact factor reflective of its reputation, BMC Research Notes ranks Q2 in Biochemistry, Genetics and Molecular Biology and holds a commendable Q3 classification in Medicine for 2023. Notably, the journal's Scopus rankings highlight its prominence, especially in General Medicine, where it stands in the 77th percentile. Situated in the United Kingdom, the journal prioritizes open access to foster transparency and engagement with a global audience, making it an essential resource for researchers, practitioners, and students who are looking to stay abreast of new findings and practical advancements within their fields. The journal continues to span evolving research themes from 2008 to 2024, ensuring a dynamic repository of knowledge in the rapidly advancing landscape of biomedical research.

International Journal of Biomedicine, published by INT MEDICAL RESEARCH & DEVELOPMENT CORP, is a premier Open Access journal dedicated to advancing knowledge in the multifaceted fields of biomedicine, including but not limited to biochemistry, genetics, immunology, microbiology, and neuroscience. With its ISSN 2158-0510 and E-ISSN 2158-0529, this journal has been serving as a significant platform for researchers since its inception in 2011, ensuring the dissemination of high-quality, peer-reviewed articles. Despite currently holding a Q4 ranking in prominent categories such as Biochemistry, Genetics and Molecular Biology and Neuroscience, the journal plays a vital role in fostering scientific dialogue and innovation in these rapidly evolving domains. The journal's commitment to accessibility further empowers both seasoned professionals and budding scholars to contribute to, and benefit from, the wealth of research that characterizes the biomedicine landscape. With a significant emphasis on interdisciplinary approaches and contemporary issues, the International Journal of Biomedicine is an essential resource for those aiming to navigate the complex intersections of health, disease, and biomedical discovery.

Bio-protocol is an innovative open-access journal dedicated to the advanced fields of biochemistry, immunology, neuroscience, and plant science, published by BIO-PROTOCOL in the United States since 2023. With an E-ISSN of 2331-8325, this journal serves as a pivotal platform for sharing high-quality methodologies and experimental protocols, enabling researchers, professionals, and students to streamline their experimental workflows and enhance reproducibility in scientific research. In 2023, Bio-protocol achieved notable rankings, placing in the Q2 category for biochemistry, genetics, molecular biology, and immunology, as well as Q3 in neuroscience, reflecting its growing influence and relevance in these fields. The journal offers full open access, ensuring that cutting-edge research is freely available, promoting global collaboration and innovation in the life sciences. Engaging with Bio-protocol positions its readers at the forefront of significant scientific advancements and methodological developments.

EXPERIMENTAL BIOLOGY AND MEDICINE is a distinguished open-access journal published by FRONTIERS MEDIA SA, specializing in the interdisciplinary fields of biochemistry, genetics, and medicine. With an ISSN of 1535-3702 and an E-ISSN of 1535-3699, this journal presents a robust platform for cutting-edge research and innovative clinical studies. Since its inception in 1996, it has evolved to feature a broad scope that caters to the evolving needs of researchers, professionals, and students, ensuring a dynamic dissemination of knowledge in biological and medical sciences. In 2023, the journal achieved a notable Q2 ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories, reflecting its strong impact and relevance within the academic community, as supported by its Scopus rank of #59 out of 221 in general biochemistry and genetics, placing it in the 73rd percentile. By offering open access options, EXPERIMENTAL BIOLOGY AND MEDICINE aims to maximize the reach and visibility of research findings, fostering collaboration and knowledge sharing across global audiences. Researchers are encouraged to contribute to this vital resource as it continues to advance the understanding of biological mechanisms and therapeutic approaches crucial for modern medicine.